Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
Phase 2
Recruiting
- Conditions
- Difficult to Control Hypertension
- Interventions
- Other: Placebo Matched control
- First Posted Date
- 2024-04-02
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- E-Star BioTech, LLC
- Target Recruit Count
- 120
- Registration Number
- NCT06343298
- Locations
- 🇺🇸
Amicis Research Center - Beverly Hills, Beverly Hills, California, United States
🇺🇸Amicis Research Center - Granada Hills, Granada Hills, California, United States
🇺🇸Orange County Research Center, Lake Forest, California, United States
Safety And Tolerability Of Subcutaneous MANP In Difficult To Control/Resistant Hypertensive Subjects
Phase 1
Completed
- Conditions
- Resistant HypertensionDifficult to Control Hypertension
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-02-21
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- E-Star BioTech, LLC
- Target Recruit Count
- 37
- Registration Number
- NCT05247528
- Locations
- 🇺🇸
USA Clinical Site 03, Anniston, Alabama, United States
🇺🇸USA Clinical Site 01, Tustin, California, United States
🇺🇸USA Clinical Site 02, DeLand, Florida, United States
News
No news found